Harvard Bioscience, Inc. Issues Letter to Shareholders | Harvard Bioscience, Inc.
Provides Update on Performance Against Previously Announced Strategic Plan HOLLISTON, Mass., May 26, 2020 (GLOBE NEWSWIRE) — Jim Green, Chairman,
Read moreHarvard Bioscience
Harvard Bioscience Announces First Quarter 2020 Financial Results | Harvard Bioscience, Inc.
Implemented significant cost reductions to offset Covid-19 impact on operating income HOLLISTON, Mass., May 05, 2020 (GLOBE NEWSWIRE) — Harvard
Read moreHarvard Bioscience Schedules First Quarter 2020 Earnings Conference Call for May 5, 2020 at 8:00 AM ET | Harvard Bioscience, Inc.
HOLLISTON, Mass., April 23, 2020 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first
Read moreHarvard Bioscience Announces Appointment of Susan Steele to Board of Directors | Harvard Bioscience, Inc.
Engine Capital Withdraws Director Nomination Notice For 2020 Annual Meeting of Stockholders HOLLISTON, Mass., April 06, 2020 (GLOBE NEWSWIRE) —
Read moreHarvard Bioscience Introduces Next Generation Inhalation System to Aid in the Fight Against COVID-19 | Harvard Bioscience, Inc.
Company will continue to manufacture and ship innovative products for global development and research throughout crisis HOLLISTON, Mass., March 23,
Read moreCORRECTION – Harvard Bioscience Announces Fourth Quarter 2019 Financial Results | Harvard Bioscience, Inc.
Substantially improves adjusted operating margins while taking actions to underpin 2020 profit and growth targets HOLLISTON, Mass., Feb. 26, 2020
Read moreHarvard Bioscience Announces Fourth Quarter 2019 Financial Results | Harvard Bioscience, Inc.
Substantially improves adjusted operating margins while taking actions to underpin 2020 profit and growth targets HOLLISTON, Mass., Feb. 26, 2020
Read moreHarvard Bioscience Schedules Fourth Quarter 2019 Earnings Conference Call for February 26, 2020 at 8:00 AM ET | Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth
Read moreHarvard Bioscience Schedules Third Quarter 2019 Earnings Conference Call for November 5 at 4:30 PM ET | Harvard Bioscience, Inc.
HOLLISTON, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its quarterly results for third
Read moreHarvard Bioscience Announces Executive Appointment | Harvard Bioscience, Inc.
HOLLISTON, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Yash Singh has been
Read moreHarvard Bioscience Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 01, 2019 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that in connection with Yash
Read moreHarvard Bioscience Announces Third Quarter Financial Results | Harvard Bioscience, Inc.
Improves adjusted operating margins while taking actions to underpin next year’s profit and growth targets Q3 Revenue of $27.4 million
Read moreHarvard Bioscience to attend Benchmark’s 8th Annual Discovery One-on-One Conference | Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 21, 2019 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President
Read more